I believed they was going to be stopped anytime from doing this by the Health directory or was they cleared from the case?
Next year, after the final patient enrolled gets their last treatment, are you allowed to say whether or not you have improved or are you sworn to secrecy until publication?I am in the study. Can't say more about that
Next year, after the final patient enrolled gets their last treatment, are you allowed to say whether or not you have improved or are you sworn to secrecy until publication?
Thanks and sorry, yes, I meant at follow up, even though I knew I was typing "treatment".Hm... I don't really know. I guess I can say what I want when all patients have completed follow-up.
What about medical tourism?
Could any of the ME associations approach doctors in Puerto Rico about rituximab for ME??
The cost of the drug is a big factor in the overall price so I don't think it would be substantially cheaper in some countries.
A summary of an old article in the Wall Street Journal (2012).
I know Reditux has been widely available in India for some time, but I didn't know that Roche had their own version in the market.
The drug is called Ikgdar and is made by Roche under the company name Emcure Pharmaceuticals Ltd.
I found some prices online:
It looks like they call it Ristova in Pakistan. Here is the brochure: http://www.roche.com.pk/content/dam/ROPEGRA/Ristova/Ristova-ra-cmi_new (1).pdf
Looks like the price is 37,500 indian rupee, or $585/£376 for 10 mg x 1 mL x 50ml.
It looks like the price in the USA is around $2840 for the same amount of Rituxan/Rituximab (wholesale). Could this be right? I know dr. Kogelnik charges around $6800 per infusion for the drug, whether it is 500mg/1g. They also charge $2000 for costs related to the infusion.
And has anyone received treatment for ME with Rituximab in India? I am very skeptical about untested biosimilars, but this product comes straight from Roche.
Dr K doesn't make money on infusing Rituximab. The cost of drugs differs in each countries. US being a very expensive place to buy medicines. Each country negociate with drug companies to purchase them.I think dr. Kogelnik takes 2x the price for RTX and almost 3x the price compared to Kolibri in Norway. I do think the price list price for Rituximab is higher in the states compared to Europe. I would guess that the price of Rituximab is the same in the US and Puerto Rico.
Roche sells a version of Rituximab in India which is extremely cheap. Check this thread out: http://forums.phoenixrising.me/index.php?threads/rituximab-in-india.38071/
Remember RTX is not approved for the treatment of ME. It would be irresponsible for an ME charity to advocate this.
It's how the world works.Not sure I understand. Re irresponsible, is that a personal opinion and/or is it also how the world works (the world's opinion), so to speak? Sigh...
Organisations who represent the community want what's best for patients. This means relying on approved medication.If doctors and patients are within their legal rights to administer/use treatment-X, and a high percentage of the patient population wants an opportunity to be evaluated for use of treatment-X, shouldn't organizations representing the community help people access an opportunity to be evaluated? Supply/demand?
Otherwise, it's death by gov bureaucracy... Government buildings should just all be stamped out in "death star" architecture... (End mini-rant.)
"Dr. Antonio Grillo-López likens them [the FDA] to the pace of snails and considers them to be 'the single most important obstacle to the timely development and approval of anti-cancer agents.' He cites examples such as the five-month-review to simply approve the proposed name for rituximab..."
https://en.wikibooks.org/wiki/Structural_Biochemistry/Rituximab